Skip to content
Screener

Clover Health Investments CLOV Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

Humana logo
HumanaHUM
InnovAge Holdings, Inc. logo
InnovAge Holdings, Inc.INNV
Globe Life logo
Globe LifeGL

Other financials

Income statement

See full
Revenue$749.2M+62.0%
Operating income$27.3M+2,246%
Net income$27.3M+2,246%
EPS (diluted)$0.05

Balance sheet

See full
Cash & equivalents$173.3M+11.5%
Total debt$3.3M-0.9%
Total equity$339.4M+1.0%
Total assets$697.7M+19.5%

Cash flow

See full
Operating cash flow$107.9M+762%
CapEx$854.0K+362%
Free cash flow$107.0M+750%

Valuation

See full
Market cap$2.43B+91.8%
P/S1.1×+0.3×

Profitability

See full
Operating margin-2.6%+3.5pp
Net margin-2.6%+2.8pp
FCF margin-10.3%

Returns & leverage

See full
Return on equity-16.9%-170pp
Debt / equity0.0×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by Clover Health Investments in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The source filing: Clover Health Investments’s 10-Q, filed May 8, 2026.

Filed
May 8, 2026, 8:06 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001801170-26-000122
Line itemMarch 31, 2026December 31, 2025
Class A Common Stock, $0.0001 par value; 2,500,000,000 shares authorized at March 31, 2026 and December 31, 2025; 429,555,578 and 426,669,369 issued and outstanding at March 31, 2026 and December 31, 2025, respectively4343
Class B Common Stock, $0.0001 par value; 500,000,000 shares authorized at March 31, 2026 and December 31, 2025; 95,715,856 and 92,373,157 issued and outstanding at March 31, 2026 and December 31, 2025, respectively99
Additional paid-in capital2,695,1442,682,663
Accumulated other comprehensive (loss) income(672)528
Accumulated deficit(2,261,018)(2,288,352)
Less: Treasury stock, at cost; 34,977,670 and 33,412,273 shares held at March 31, 2026 and December 31, 2025, respectively(94,080)(86,187)
Total stockholders' equity339,426308,704
Total liabilities and stockholders' equity$697,728$541,011

Item 1. Financial Statements (Unaudited)

FAQ

What is Clover Health Investments's treasury stock, shares (in shares)?
Clover Health Investments (CLOV) reported treasury stock, shares (in shares) of $34.98M in Q1 2026.
How has Clover Health Investments's treasury stock, shares (in shares) changed year-over-year?
Clover Health Investments's treasury stock, shares (in shares) increased by 36.3% year-over-year, from $25.66M to $34.98M.
What is the long-term trend for Clover Health Investments's treasury stock, shares (in shares)?
Over 4 years (2021 to 2025), Clover Health Investments's treasury stock, shares (in shares) has grown at a 590.1% compound annual growth rate (CAGR), from $14.73K to $33.41M.

Ask your AI about Clover Health Investments's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude